This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reinhardt, U. E. Search for Related Content PubMed PubMed Citation Articles by Reinhardt, U. E. Related Collections Health Reform Pharmaceuticals Research And Technology

Costs In Context

Perspectives On The Pharmaceutical Industry

This paper seeks to provide an economic perspective on the pharmaceutical industry, which has come under increasing criticism on a number of issues. In the main, that criticism amounts to a rather ineffective flailing at the supply side of the market for pharmaceutical products—much of it based on inaccurate perceptions—when a more productive policy would be to strengthen the hitherto weak and poorly informed demand side of the market.

                      What's this?

This article has been cited by other articles:

				F. Simon Market Access For Biopharmaceuticals: New Challenges Health Aff., September 1, 2006; 25(5): 1363 - 1370. [Abstract] [Full Text] [PDF]